Incidence of Plasmodium Vivax Malaria in Patients with Pancytopenia

Main Article Content

Niktash Khan Hadi
Muhammad Kashif Nouman
Farooq Marwat
Shahmir Tariq Khan
Hamd E Yazdaan
Nizamud Din


Background: Malaria, caused by Plasmodium vivax, is prevalent in many tropical and subtropical regions of the world, notably in South Asia and Africa. The clinical manifestation of malaria, including pancytopenia, varies widely, leading to complex challenges in diagnosis and treatment. Understanding the association between Vivax malaria and hematological abnormalities like pancytopenia is critical for improving patient outcomes in endemic regions.

Objective: This study aimed to investigate the incidence of Plasmodium vivax in patients presenting with pancytopenia and to assess the demographic and hematological profiles of these patients in a high-prevalence area.

Methods: A prospective cohort study was conducted at the Hayatabad Medical Complex, Peshawar, from January 2021 to January 2023. A total of 350 patients who presented at the medical outpatient department were enrolled based on inclusion and exclusion criteria. Blood samples were collected using aseptic techniques, and peripheral blood smears were prepared for analysis. Demographic data were collected through questionnaires. Statistical analysis was performed using SPSS version 25, with categorical data analyzed using Chi-square tests and continuous variables using t-tests, setting statistical significance at p < 0.05.

Results: Of the 350 patients studied, 71.4% were male and 28.6% were female, with a mean age of 55.1 years. The hemoglobin levels averaged 8.86 g/dl (SD ± 1.77), and the leukocyte count was 2.84×10^3/Cmm (SD ± 3.31). Platelet counts averaged 77.25×10^9/Cmm (SD ± 2.90). Overall, 52.6% of patients tested positive for P. vivax. There were no significant differences in the incidence of P. vivax infection across age groups (p = 0.36) or between genders (p = 0.41).

Conclusion: The study confirmed a significant prevalence of P. vivax in patients with pancytopenia, highlighting the need for routine screening in malaria-endemic regions. Early diagnosis and treatment are essential for managing pancytopenia in patients with malaria and can lead to substantial improvements in clinical outcomes.

Article Details

How to Cite
Hadi , N. K., Nouman , M. K., Marwat , F., Khan , S. T., Yazdaan , H. E., & Din , N. (2024). Incidence of Plasmodium Vivax Malaria in Patients with Pancytopenia. Journal of Health and Rehabilitation Research, 4(2), 100–104.
Author Biographies

Niktash Khan Hadi , Hayatabad Medical Complex Peshawar Pakistan.

Department of Diabetes, Endocrinology and Metabolic Diseases, Hayatabad Medical Complex, Peshawar, Pakistan.

Muhammad Kashif Nouman , Khyber Teaching Hospital- Peshawar- Pakistan.

Department of Internal Medicine, Khyber Teaching Hospital- Peshawar- Pakistan.

Farooq Marwat , Hayatabad Medical Complex Peshawar Pakistan.

Department of Internal Medicine, Hayatabad Medical Complex, Peshawar, Pakistan.

Shahmir Tariq Khan , Hayatabad Medical Complex Peshawar Pakistan.

Department of Diabetes, Endocrinology and Metabolic Diseases, Hayatabad Medical Complex, Peshawar, Pakistan.

Hamd E Yazdaan , Khyber Teaching Hospital Peshawar Pakistan.

Department of Internal Medicine, Khyber Teaching Hospital- Peshawar- Pakistan.

Nizamud Din , Hayatabad Medical Complex Peshawar Pakistan.

Department of Diabetes, Endocrinology and Metabolic Diseases, Hayatabad Medical Complex, Peshawar, Pakistan.


Gething PW, Patil AP, Smith DL, et al. A New World Malaria Map: Plasmodium Falciparum Endemicity in 2010. Malar J. 2011;10:378. doi:10.1186/1475-2875-10-378.

Thriemer K, Ley B, Bobogare A, et al. Challenges for Achieving Safe and Effective Radical Cure of Plasmodium Vivax: A Round Table Discussion of the APMEN Vivax Working Group. Malar J. 2017;16:141. doi:10.1186/s12936-017-1784-1.

Zubairi AB, Nizami S, Raza A, et al. Severe Plasmodium Vivax Malaria in Pakistan. Emerg Infect Dis. 2013;19:1851-4. doi:10.3201/eid1911.130495.

Hoo R, Zhu L, Amaladoss A, et al. Integrated Analysis of the Plasmodium Species Transcriptome. EBioMedicine. 2016;7:255-66. doi:10.1016/j.ebiom.2016.04.011.

Lin JT, Parr JB, Ngasala B. Non-Falciparum Malaria in Africa and Learning from Plasmodium Vivax in Asia. Clin Infect Dis. 2019;70:2018-9. doi:10.1093/cid/ciz780.

Taylor JE, Pacheco MA, Bacon DJ, et al. The Evolutionary History of Plasmodium Vivax as Inferred from Mitochondrial Genomes: Parasite Genetic Diversity in the Americas. Mol Biol Evol. 2013;30:2050-64. doi:10.1093/molbev/mst104.

Gai PP, Mockenhaupt FP, Siegert K, et al. Manifestation of Malaria in Mangaluru, Southern India. Malar J. 2018;17:313. doi:10.1186/s12936-018-2462-7.

Gudina EK, Amare H, Benti K, et al. Pancytopenia of Unknown Cause in Adult Patients Admitted to a Tertiary Hospital in Ethiopia: Case Series. Ethiop J Health Sci. 2018;28:375-82. doi:10.4314/ejhs.v28i4.3.

Tadesse F, Fogarty AW, Deressa W. Prevalence and Associated Risk Factors of Malaria Among Adults in East Shewa Zone of Oromia Regional State, Ethiopia: A Cross-Sectional Study. BMC Public Health. 2017;18:25. doi:10.1186/s12889-017-4577-0.

Tanizaki R, Ujiie M, Kato Y, et al. First Case of Plasmodium Knowlesi Infection in a Japanese Traveler Returning from Malaysia. Malar J. 2013;12:28. doi:10.1186/1475-2875-12-128.

Raina V, Sharma A, Gujral S, et al. Plasmodium Vivax Causing Pancytopenia After Allogeneic Blood Stem Cell Transplantation in CML. Bone Marrow Transplant. 1998;22:205-6. doi:10.1038/sj.bmt.1701299.

Bhagat M, Kanhere S, Phadke V, George R. Concurrent Malaria and Dengue Fever: A Need for Rapid Diagnostic Methods. J Family Med Prim Care. 2014;3:446-8. doi:10.4103/2249-4863.148146.

Mahgoub H, Gasim GI, Musa IR, Adam I. Severe Plasmodium Vivax Malaria Among Sudanese Children at New Halfa Hospital, Eastern Sudan. Parasites Vectors. 2015;5:154. doi:10.1186/1756-3305-5-154.

Mohapatra MK, Padhiary KN, Mishra DP, Sethy G. Atypical Manifestations of Plasmodium Vivax Malaria. Indian J Malariol. 2002;39:18-25.

Simões LR, Alves Jr ER, Ribatski-Silva D, Gomes LT, Nery AF, Fontes CJF. Factors Associated with Recurrent Plasmodium Vivax Malaria in Porto Velho, Rondônia State, Brazil, 2009. Cad Saude Publica. 2014;30:10. doi:10.1590/0102-311X00169312.

Sondén K, Castro E, Trönnberg L, Stenström C, Tegnell A, Färnert A. High Incidence of Plasmodium Vivax Malaria in Newly Arrived Eritrean Refugees in Sweden Since May 2014. Eurosurveillance. 2014;19:20890. doi:10.2807/1560-7917.ES2014.19.35.20890.

Ahmad S, Ikramullah Q, Ahmad I. Frequency of Thrombocytopenia in malaria and its prognostic significance. Journal of University Medical & Dental College. 2023 Feb 15;14(1):545-8.

Orish VN, Lokpo SY, Kwadzokpui PK, Safianu R, Marinkovic A, Prakash S, Okorie C, Izurieta R, Pandit R, Sanyaolu A. Association between asymptomatic Plasmodium falciparum malaria infection, anaemia and mean corpuscular volume of school children in the Volta Region of Ghana. European Journal of Microbiology and Immunology. 2024 Feb 26.

Goyal JP, Makwana AM. Research Article Comparison of Clinical Profile between P. vivax and P. falciparum Malaria in Children: A Tertiary Care Centre Perspective from India.

Gupta N, Chalotra S, Parihar RK, Sharma P. Ramifications of pancytopenia in children in a tertiary care center in North Indian. Journal of Applied Hematology. 2023 Apr 1;14(2):95-100.